Finding the ‘Guilty’ Gene Variant of Sporadic Parkinson’s Disease Via CRISPR/Cas9

被引:0
|
作者
Shenzhao Lu
Jiawei Zhou
机构
[1] Chinese Academy of Sciences,Institute of Neuroscience, State Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences
来源
Neuroscience Bulletin | 2017年 / 33卷
关键词
Parkinson’s disease; Genetic variant; CRISPR/Cas9;
D O I
暂无
中图分类号
学科分类号
摘要
Parkinson’s disease (PD) is a common neurodegenerative disorder affecting millions of people worldwide, but its cause and pathogenesis are still not fully understood. Earlier studies have shown that SNCA, which encodes α-synuclein, is one of the key genes associated with PD. Single-nucleotide polymorphism (SNP) variants of SNCA are thought to be correlated with disease onset. The underlying mechanisms however are enigmatic. A recent study published in Nature revealed that one of the SNP variants in the SNCA non-coding element elevated α-synuclein expression in human neurons by reducing the binding efficiency of transcription factors, demonstrating a previously uncharted role for SNPs in the pathogenesis of PD.
引用
收藏
页码:115 / 117
页数:2
相关论文
共 50 条
  • [41] CRISPR/Cas9 System and its Research Progress in Gene Therapy
    Liu, Wenlou
    Yang, Chunsheng
    Liu, Yanqun
    Jiang, Guan
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (16) : 1912 - 1919
  • [42] CRISPR/Cas9 genetic screens in hepatocellular carcinoma gene discovery
    Chiu, Cynthia H.
    CURRENT RESEARCH IN BIOTECHNOLOGY, 2023, 5
  • [43] Off-target effects in CRISPR/Cas9 gene editing
    Guo, Congting
    Ma, Xiaoteng
    Gao, Fei
    Guo, Yuxuan
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2023, 11
  • [44] Cancer Gene Discovery in Hepatocellular Carcinoma: The CRISPR/CAS9 Accelerator
    Nault, Jean-Charles
    GASTROENTEROLOGY, 2017, 152 (05) : 941 - 943
  • [45] Recent advances of CRISPR/Cas9 gene editing in the treatment of β-thalassemia
    Jie, Qian
    Lei, Shuangyin
    Qu, Chao
    Wu, Hao
    Liu, Yingru
    Huang, Ping
    Teng, Shuzhi
    CHINESE SCIENCE BULLETIN-CHINESE, 2022, 67 (21): : 2492 - 2508
  • [46] Application of CRISPR/Cas9 System for Efficient Gene Editing in Peanut
    Neelakandan, Anjanasree K.
    Wright, David A.
    Traore, Sy M.
    Ma, Xingli
    Subedi, Binita
    Veeramasu, Suman
    Spalding, Martin H.
    He, Guohao
    PLANTS-BASEL, 2022, 11 (10):
  • [47] Delivery of CRISPR/Cas9 system by AAV as vectors for gene therapy
    Wang, Yanan
    Jiang, Haibin
    Li, Mopu
    Xu, Zidi
    Xu, Hang
    Chen, Yuetong
    Chen, Kepei
    Zheng, Weihong
    Lin, Wei
    Liu, Zhiming
    Lin, Zhenlang
    Zhang, Min
    GENE, 2024, 927
  • [48] CRISPR/Cas9 technology as a potent molecular tool for gene therapy
    Karimian, Ansar
    Azizian, Khalil
    Parsian, Hadi
    Rafieian, Sona
    Shafiei-Irannejad, Vahid
    Kheyrollah, Maryam
    Yousefi, Mehdi
    Majidinia, Maryam
    Yousefi, Bahman
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (08) : 12267 - 12277
  • [49] Gene editing by CRISPR/Cas9 in the obligatory outcrossing Medicago sativa
    Ruimin Gao
    Biruk A. Feyissa
    Mana Croft
    Abdelali Hannoufa
    Planta, 2018, 247 : 1043 - 1050
  • [50] Gene editing in mouse zygotes using the CRISPR/Cas9 system
    Wefers, Benedikt
    Bashir, Sanum
    Rossius, Jana
    Wurst, Wolfgang
    Kuehn, Ralf
    METHODS, 2017, 121 : 55 - 67